Boehringer Ingelheim
Home
Therapeutic Area: Virology
 

Disease State: Hepatitis C

Educational Objectives

  1. Improve healthcare provider’s knowledge of risks associated with chronic HCV infection
    1. Improve awareness of risks of liver morbidity and mortality associated with undiagnosed HCV and under-treatment of HCV disease.
    2. Increase knowledge of HCV support resources.
  2. Increase patient’s and healthcare provider’s knowledge of modes of exposure to HCV infection.
    1. Improve healthcare provider’s ability to select for screening, those individuals at high risk for HCV.
    2. Improve healthcare provider’s attitudes regarding risk behaviors and sensitivity toward socio-demographically distinguishable high risk sub-populations.
  3. Improve healthcare provider’s knowledge of the goals of treatment for patients with chronic HCV infection and co-morbidities with HCV (e.g. HIV)
    1. Improve healthcare provider’s awareness of barriers to treatment, options for treatment resistance and treatment failures, and approaches to mitigate and manage treatment-induced side effects.
  4. Ensure healthcare provider’s awareness of the current standard of care of chronic HCV infection.
    1. Increase healthcare provider’s knowledge of emerging adjunctive therapeutic options.
  5. Ensure healthcare providers understanding of the potential development of drug resistance and the need to optimize therapeutic options.